Huron Life Sciences Gains Managing Director

Huron Consulting Group (HCG) has named Brad Dawson the new managing director of its Huron Life Sciences division. Dawson will advise pharmaceutical and medical device companies on research and development (R&D) to improve operational efficiencies, address regulatory compliance vulnerabilities, and enhance the overall value of the development pipeline.

“The life sciences industry is facing increased pressure to be more cost effective in its research and meet ongoing regulatory demands,” said Paul Silver, managing director of HCG and Huron Life Sciences solution leader. “Brad will help pharmaceutical and medical device clients improve their R&D processes to achieve better efficiencies in meeting regulatory and cost challenges. His expertise will help clients more efficiently integrate knowledge management, improve patient safety, and enhance functional operations to reduce time to market. We are pleased to welcome Brad to the Huron Life Sciences team and are confident that his deep experience will be a tremendous resource for our clients in this critical area.”

Dawson has more than 15 years of experience leading strategic growth initiatives, process improvement, and quality system optimization solutions for pharmaceutical, biotechnology and medical device companies. Prior to joining Huron Life Sciences, Dawson worked at Quintiles Consulting where he served as the principal and practice leader for R&D process optimization. At Huron, Dawson will work with clients on solutions that transform core business and information management processes from early research and development through clinical operations, regulatory and quality management, and tech transfer.

The Huron Life Sciences practice provides a variety of consultation services to companies in the medical market, including medical device manufacturers. Huron Consulting Group is headquartered in Chicago, Ill.